Low parathyroid hormone levels in bedridden geriatric patients with vitamin D deficiency

Journal of the American Geriatrics Society

Volumn 57, Issue 6, 2009, Pages 1045-1050

  Björkman, Mikko P ^a,b   Sorva, Antti J ^c   Risteli, Juha ^d   Tilvis, Reijo S ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Helsinki Research Center   (Finland)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

Aged patients; Chronic immobilization; Hip fracture; Parathyroid hormone

Indexed keywords

COLECALCIFEROL; PARATHYROID HORMONE;

AGED; ANAMNESIS; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; VITAMIN D DEFICIENCY;

ACTIVITIES OF DAILY LIVING; AGED, 80 AND OVER; BODY MASS INDEX; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HIP FRACTURES; HUMANS; MALE; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PROCOLLAGEN; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 66549087986     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2009.02257.x     Document Type: Article

References (30)

1. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001 22 : 477 501. (Pubitemid 32762324)
2. Mosekilde L. Vitamin D and the elderly. Clin Endocrinol (Oxford) 2005 62 : 265 281. (Pubitemid 40380406)
3. Heath H III, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: Incidence, morbidity, and potential economic impact in a community. N Engl J Med 1980 302 : 189.
4. Sorva A, Valvanne J, Tilvis RS Serum ionized calcium and the prevalence of primary hyperparathyroidism in age cohorts of 75, 80 and 85 years. J Intern Med 1992 231 : 309 312.
5. Khosla S, Melton LJ III., Wermers RA et al. Primary hyperparathyroidism and the risk of fracture: A population-based study. J Bone Miner Res 1999 14 : 1700 1707. (Pubitemid 29455818)
6. Conroy S, Moulias S, Wassif WS. Primary hyperparathyroidism in the older person. Age Ageing 2003 32 : 571 578. (Pubitemid 37461563)
7. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006 92 : 4 8. (Pubitemid 43831956)
8. Need A. Bone resorption markers in vitamin D insufficiency. Clin Chim Acta 2006 368 : 48 52. (Pubitemid 43776018)
9. Chapuy MC, Arlot ME, Duboeuf F et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992 327 : 1637 1642.
10. Avenell A, Gillespie WJ, Gillespie LD et al. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2005;20:CD000227.
11. Morley P, Whitfield JF, Willick GE. Design and applications of parathyroid hormone analogues. Curr Med Chem 1999 6 : 1095 1106. (Pubitemid 29496042)
12. Neer RM, Arnaud CD, Zanchetta JR et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001 344 : 1434 1441. (Pubitemid 32402100)
13. Thomas T. Intermittent parathyroid hormone therapy to increase bone formation. Joint Bone Spine 2006 73 : 262 269.
14. Björkman M, Sorva A, Risteli J et al. Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D deficient bedridden older patients. Age Ageing 2008 37 : 25 31.
15. Kao PC, Grant CS, Klee GG et al. Clinical performance of parathyroid hormone immunometric assays. Mayo Clin Proc 1992 67 : 637 645.
16. Turpeinen U, Hohenthal U, Stenman U-H. Determination of 25-hydroxyvitamin D in serum by HPLC and immunoassay. Clin Chem 2003 49 : 1521 1524. (Pubitemid 37011742)
17. Risteli J, Elomaa I, Niemi S et al. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 1993 39 : 635 640.
18. Melkko J, Kauppila S, Niemi S et al. Immunoassay for the intact aminoterminal propeptide of human type I procollagen (PINP). Clin Chem 1996 42 : 947 954.
19. Morris JN, Fries BE, Morris SA. Scaling ADLs within the MDS. J Gerontol A Biol Sci Med Sci 1999 54A : M546 M553.
20. Heaney R, Dowell M, Hale C et al. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003 22 : 142 146. (Pubitemid 36417827)
21. Lips P. Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 2004 89-90 : 611 614. (Pubitemid 38844358)
22. Sahota O, Gaynor K, Harwood RH et al. Hypovitaminosis D and 'functional hypoparathyroidism'-the NoNoF (Nottingham Neck of Femur) study. Age Ageing 2001 30 : 467 472. (Pubitemid 34071485)
23. Fisher AA, Davis MW. Is the current anti-osteoporotic therapy paradigm good enough? J Am Geriatr Soc 2006 54 : 1960 1961. (Pubitemid 44915857)
24. Bikle D, Halloran B. The response of bone to unloading. J Bone Miner Metab 1999 17 : 233 244.
25. Lips P, van Ginkel FC, Netelenbos JC et al. Lower mobility and markers of bone resorption in the elderly. Bone Miner 1990 9 : 49 57. (Pubitemid 20100900)
26. Sorva A, Välimäki M, Risteli J et al. Serum ionized calcium and novel markers of bone turnover in bedridden elderly patients. Eur J Clin Invest 1994 24 : 806 812. (Pubitemid 24374776)
27. Bischoff H, Stahelin HB, Vogt P et al. Immobility as a major cause of bone remodeling in residents of a long-stay geriatric ward. Calcif Tissue Int 1999 64 : 485 489. (Pubitemid 29244791)
28. Sato Y, Kuno H, Asoh T et al. Effect of immobilization on vitamin D status and bone mass in chronically hospitalized disabled stroke patients. Age Ageing 1999 28 : 265 269. (Pubitemid 29229329)
29. Chen JS, Cameron ID, Cumming RG et al. Effect of age-related chronic immobility on markers of bone turnover. J Bone Miner Res 2006 21 : 324 331. (Pubitemid 43265299)
30. Souberbielle JC, Friedlander G, Cormier C. Practical considerations in PTH testing. Clin Chim Acta 2006 366 : 81 89. (Pubitemid 43330969)